Schroder Investment Management Group Lowers Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Schroder Investment Management Group lowered its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 41.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 6,915 shares of the company's stock after selling 4,926 shares during the period. Schroder Investment Management Group's holdings in HealthEquity were worth $666,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Arcadia Investment Management Corp MI purchased a new stake in HealthEquity during the fourth quarter worth $26,000. Smartleaf Asset Management LLC raised its position in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after acquiring an additional 98 shares during the period. Proficio Capital Partners LLC acquired a new position in shares of HealthEquity in the fourth quarter worth about $39,000. UMB Bank n.a. boosted its stake in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after acquiring an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ grew its position in shares of HealthEquity by 1,934.8% during the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after acquiring an additional 445 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at $4,433,820.30. This represents a 13.55 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 20,381 shares of company stock worth $1,781,432. 2.20% of the stock is owned by corporate insiders.

Remove Ads

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on HQY. Wells Fargo & Company upped their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. KeyCorp reduced their target price on HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Monday, March 24th. The Goldman Sachs Group dropped their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their price objective for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Finally, Barrington Research reiterated an "outperform" rating and issued a $112.00 target price on shares of HealthEquity in a research report on Friday. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, HealthEquity presently has an average rating of "Buy" and a consensus price target of $112.58.

HealthEquity Price Performance

HQY traded up $2.26 during trading on Friday, reaching $82.20. The company's stock had a trading volume of 926,462 shares, compared to its average volume of 759,548. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a fifty day simple moving average of $97.63 and a two-hundred day simple moving average of $96.30. The company has a market cap of $7.11 billion, a price-to-earnings ratio of 75.41, a PEG ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.